These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 11115734

  • 21. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
    Preston KL, Bigelow GE.
    J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Review of self-administration.
    Balster RL, Lukas SE.
    Drug Alcohol Depend; 1985 Feb; 14(3-4):249-61. PubMed ID: 3888576
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of Full µ-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence.
    van Niel JC, Schneider J, Tzschentke TM.
    Drug Res (Stuttg); 2016 Nov; 66(11):562-570. PubMed ID: 27504867
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Buprenorphine-induced alterations of cocaine's reinforcing effects in rhesus monkey: a dose-response analysis.
    Lukas SE, Mello NK, Drieze JM, Mendelson JH.
    Drug Alcohol Depend; 1995 Nov; 40(1):87-98. PubMed ID: 8746929
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Drug discrimination in human postaddicts: agonist-antagonist opioids.
    Preston KL, Bigelow GE, Bickel WK, Liebson IA.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
    [Abstract] [Full Text] [Related]

  • 29. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    Zimmerman DM, Leander JD, Reel JK, Hynes MD.
    J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
    [Abstract] [Full Text] [Related]

  • 30. Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: importance of training dose and attenuation by the D3 agonist (+/-)-7-OH-DPAT.
    Cook CD, Picker MJ.
    Psychopharmacology (Berl); 1998 Mar; 136(1):59-69. PubMed ID: 9537683
    [Abstract] [Full Text] [Related]

  • 31. Discrimination of butorphanol and nalbuphine in opioid-dependent humans.
    Preston KL, Bigelow GE, Liebson IA.
    Pharmacol Biochem Behav; 1990 Nov; 37(3):511-22. PubMed ID: 1708145
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effects of chronic buprenorphine on intake of heroin and cocaine in rats and its effects on nucleus accumbens dopamine levels during self-administration.
    Sorge RE, Stewart J.
    Psychopharmacology (Berl); 2006 Sep; 188(1):28-41. PubMed ID: 16902770
    [Abstract] [Full Text] [Related]

  • 38. Effects of the mixed mu/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men.
    Mello NK, Mendelson JH, Sholar MB, Jaszyna-Gasior M, Goletiani N, Siegel AJ.
    Neuropsychopharmacology; 2005 Mar; 30(3):618-32. PubMed ID: 15602503
    [Abstract] [Full Text] [Related]

  • 39. Tolerance and cross tolerance to the accuracy- and rate-decreasing effects of mu opioids in rats responding under a fixed-consecutive-number schedule.
    Smith MA, Pitts RC, Picker MJ.
    Drug Alcohol Depend; 1997 Jun 06; 46(1-2):19-30. PubMed ID: 9246550
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.